These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 33599108)

  • 1. Synthesis and Assessment of Fused β-Carboline Derivatives as Kappa Opioid Receptor Agonists.
    Yadav VD; Kumar L; Kumari P; Kumar S; Singh M; Siddiqi MI; Yadav PN; Batra S
    ChemMedChem; 2021 Jun; 16(12):1917-1926. PubMed ID: 33599108
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Discovery of New Antagonist and Biased Agonist Chemotypes for the Kappa Opioid Receptor.
    Zheng Z; Huang XP; Mangano TJ; Zou R; Chen X; Zaidi SA; Roth BL; Stevens RC; Katritch V
    J Med Chem; 2017 Apr; 60(7):3070-3081. PubMed ID: 28339199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morphinan derivatives with an oxabicyclo[3.2.1]octane structure as dual agonists toward δ and κ opioid receptors.
    Uenohara Y; Tsumura S; Hirayama S; Higashi E; Watanabe Y; Gouda H; Nagase H; Fujii H
    Bioorg Med Chem; 2022 Jan; 53():116552. PubMed ID: 34894610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Activity Relationships of [des-Arg
    Ramos-Colon CN; Lee YS; Remesic M; Hall SM; LaVigne J; Davis P; Sandweiss AJ; McIntosh MI; Hanson J; Largent-Milnes TM; Vanderah TW; Streicher J; Porreca F; Hruby VJ
    J Med Chem; 2016 Nov; 59(22):10291-10298. PubMed ID: 27797517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of kappa opioid receptor mediated, dynorphin-stimulated [35S]GTPγS binding in mouse striatum for the evaluation of selective KOR ligands in an endogenous setting.
    Zhou L; Stahl EL; Lovell KM; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():131-41. PubMed ID: 26160155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential for Kappa-Opioid Receptor Agonists to Engineer Nonaddictive Analgesics: A Narrative Review.
    Kaski SW; White AN; Gross JD; Siderovski DP
    Anesth Analg; 2021 Feb; 132(2):406-419. PubMed ID: 33332902
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of Kappa Opioid Receptor Inactivation Depends on Sex and Cellular Site of Antagonist Action.
    Reichard KL; Newton KA; Rivera ZMG; Sotero de Menezes PM; Schattauer SS; Land BB; Chavkin C
    Mol Pharmacol; 2020 Nov; 98(5):548-558. PubMed ID: 32913138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid Receptor Modulators with a Cinnamyl Group.
    Ravilla L; Venkata Subba Naidu N; Dogra S; Umrao D; Yadav PN; Biswas A; Michael D; Sekar K; Nagarajan K
    J Med Chem; 2017 Aug; 60(15):6733-6750. PubMed ID: 28726402
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The G protein-biased κ-opioid receptor agonist RB-64 is analgesic with a unique spectrum of activities in vivo.
    White KL; Robinson JE; Zhu H; DiBerto JF; Polepally PR; Zjawiony JK; Nichols DE; Malanga CJ; Roth BL
    J Pharmacol Exp Ther; 2015 Jan; 352(1):98-109. PubMed ID: 25320048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estrogen Regulation of GRK2 Inactivates Kappa Opioid Receptor Signaling Mediating Analgesia, But Not Aversion.
    Abraham AD; Schattauer SS; Reichard KL; Cohen JH; Fontaine HM; Song AJ; Johnson SD; Land BB; Chavkin C
    J Neurosci; 2018 Sep; 38(37):8031-8043. PubMed ID: 30076211
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nalfurafine is a G-protein biased agonist having significantly greater bias at the human than rodent form of the kappa opioid receptor.
    Schattauer SS; Kuhar JR; Song A; Chavkin C
    Cell Signal; 2017 Apr; 32():59-65. PubMed ID: 28088389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of kappa opioid receptor agonists on fentanyl vs. food choice in male and female rats: contingent vs. non-contingent administration.
    Townsend EA
    Psychopharmacology (Berl); 2021 Apr; 238(4):1017-1028. PubMed ID: 33404739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
    Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cell-based, high-throughput homogeneous time-resolved fluorescence assay for the screening of potential κ-opioid receptor agonists.
    Wang Y; Yan M; Zheng GY; He L; Yang H
    Acta Pharmacol Sin; 2014 Jul; 35(7):957-66. PubMed ID: 24930486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morphine can produce analgesia via spinal kappa opioid receptors in the absence of mu opioid receptors.
    Yamada H; Shimoyama N; Sora I; Uhl GR; Fukuda Y; Moriya H; Shimoyama M
    Brain Res; 2006 Apr; 1083(1):61-9. PubMed ID: 16530171
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Pharmacological Heterogeneity of Nepenthone Analogs in Conferring Highly Selective and Potent κ-Opioid Agonistic Activities.
    Li W; Long JD; Qian YY; Long Y; Xu XJ; Wang YJ; Shen Q; Wang ZN; Yang XC; Xiao L; Sun HP; Xu YL; Chen YY; Xie Q; Wang YH; Shao LM; Liu JG; Qiu ZB; Fu W
    ACS Chem Neurosci; 2017 Apr; 8(4):766-776. PubMed ID: 28033462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and In Vivo Evaluation of Myelination Agent PIPE-3297, a Selective Kappa Opioid Receptor Agonist Devoid of β-Arrestin-2 Recruitment Efficacy.
    Schrader TO; Lorrain KI; Bagnol D; Edu GC; Broadhead A; Baccei C; Poon MM; Stebbins KJ; Xiong Y; Lorenzana AO; Chan JR; Green AJ; Lorrain DS; Chen A
    ACS Chem Neurosci; 2024 Feb; 15(3):685-698. PubMed ID: 38265210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A systematic review on the kappa opioid receptor and its ligands: New directions for the treatment of pain, anxiety, depression, and drug abuse.
    Khan MIH; Sawyer BJ; Akins NS; Le HV
    Eur J Med Chem; 2022 Dec; 243():114785. PubMed ID: 36179400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery, structure-activity relationship studies, and anti-nociceptive effects of 1-phenyl-3,6,6-trimethyl-1,5,6,7-tetrahydro-4H-indazol-4-one as novel opioid receptor agonists.
    Cheng MF; Ou LC; Chen SC; Chang WT; Law PY; Loh HH; Chao YS; Shih C; Yeh SH; Ueng SH
    Bioorg Med Chem; 2014 Sep; 22(17):4694-703. PubMed ID: 25087049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of kappa-opioid receptors in visceral nociception in mice.
    Larsson MH; Bayati A; Lindström E; Larsson H
    Neurogastroenterol Motil; 2008 Oct; 20(10):1157-64. PubMed ID: 18643891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.